Home

Search form

Introduction

Northern Finland Birth Cohorts Studies, NFBC

Persons in chage: Scientific Director, professor Marjo-Riitta Järvelin, Managing Director, professor Sirkka Keinänen-Kiukaanniemi, Vice Director, professor Anja Taanila.

Decription: Well-being and Health: The Northern Finland Birth Cohort Studies is the epidemilogical and longitudinal research program which aims to promote health and well-being of the population. The prospective data collected from the Northern Finland forms an unique resource, allowing to study the emergence of diseases which can be based on genetic, biological, social or behavioural risk factors.

The studies are comprised of the two longitudinal cohorts of mothers living in the two northernmost provinces of Finland, Oulu and Lapland with expected dates of delivery falling in NFBC 1966 between Jan 1st - Dec 31st, 1966 (12 068 mothers, 12 231 children), and in NFBC 1986 between July 1st, 1985 and June 30th, 1986 (mothers 9 362, children 9 479). In both study population, mothers and children have been followed up since mothers enrolled at their first antenatal clinic visit.

The assets of this programme lie in a strong network of the world’s leading epidemiologists, statisticians, geneticists, biochemists, physiologists, endocrinologists and clinicians and availability of the prospective data collected from before birth until middle age, spanning over three generations (in total ~70,000 parents, children and grandchildren with early prenatal information, genetic data, nutritional, metabolic[omic], inflammatory and glucose tolerance.

Period: 1965-

Collaborators and financing: Oulu University Hospital, Institute for Health and Welfare, Instute of Occupational Health, University of Helsinki, University of Eastern Finland, University of Tampere, University of California (UCLA), University of Oxford, University of Cambridge, Medical Research Council, Imperial College London, University of Bristol, University of Athene, University of Copenhagen, Uppsala University and University of Bergen.
The research is funded by among others Academy of Finland, Oulu University Hospital, Medical Research Council, EU, NIH (USA), Welcome Trust (UK).

More information: Scientific Director Marjo-Riitta Järvelin (m.jarvelin at imperial.ac.uk), Managing Director Sirkka Keinänen-Kiukaanniemi (sirkka.keinanen-kiukaanniemi at oulu.fi), Vice Director Anja Taanila (anja.taanila at oulu.fi)